Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

STO/CRNO.B stock hub

STO/CRNO.B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/CRNO.Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/CRNO.B

In the news

Latest news · STO/CRNO.B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-53

P25 n/aP50 n/aP75 n/a

ROIC-12.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/CRNO.B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

SEK

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	10
Employees Change	5%
Employees Change Percent	100
Enterprise value	SEK 1.8B
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	SEK 1.7B
Price	SEK 5.55
Price currency	SEK
Rev Per Employee	4,427,319.2x
Sector	Healthcare
Sic	2834
Symbol	sto/CRNO.B
Website	https://www.cerenoscientific.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.8%
EV Earnings	-15.14x
EV/FCF	-15.92x
EV/Sales	40.26x
FCF yield	-6.46%
P/B ratio	6.86x
P/S ratio	39.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-168.5%
EBITDA Margin	-166.72%
Gross margin	100%
Gross Profit	SEK 44.3M
Gross Profit Growth	-45.28%
Gross Profit Growth Q	-16.04%
Gross Profit Growth3 Y	-8.36%
Gross Profit Growth5 Y	40.03%
Net Income	SEK -117.8M
Pretax Margin	-265.97%
Profit Margin	-265.97%
Profit Per Employee	SEK -11.8M
ROA	-11.42
Roa5y	-10.08
ROCE	-19.76
ROE	-53
Roe5y	-30.34
ROIC	-12.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-35.82%
Cagr3y	97.6%
Cagr5y	15.68%
Revenue Growth	-45.28x
Revenue Growth Q	-16.04x
Revenue Growth3 Y	-8.36x
Revenue Growth5 Y	40.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.11
Assets	SEK 402.7M
Cash	SEK 74.6M
Current Assets	SEK 78.4M
Current Liabilities	SEK 25.2M
Debt	SEK 125M
Debt Equity	SEK 0.5
Debt FCF	SEK -1.12
Equity	SEK 252.5M
Interest Coverage	-1.67
Liabilities	SEK 150.2M
Long Term Assets	SEK 324.3M
Long Term Liabilities	SEK 125M
Net Cash	SEK -50.4M
Net Cash By Market Cap	SEK -2.91
Net Debt Equity	SEK 0.2
Tangible Book Value	SEK 238.7M
Tangible Book Value Per Share	SEK 0.77
WACC	5.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.11
Net Working Capital	SEK -21.5M
Quick ratio	3.04
Working Capital	SEK 53.1M
Working Capital Turnover	SEK 0.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-35.8%
200-day SMA	7.51
3Y total return	671.91%
50-day SMA	6.14
50-day SMA vs 200-day SMA	50under200
5Y total return	107.09%
All Time High	11.9
All Time High Change	-53.36%
All Time High Date	2025-05-20
All Time Low	0.45
All Time Low Change	1,141.61%
All Time Low Date	2023-06-05
ATR	0.27
Beta	-0.15
Beta1y	0.14
Beta2y	0.61
Ch YTD	-20.6
High	5.67
High52	11.9
High52 Date	2025-05-20
High52ch	-53.36%
Low	5.51
Low52	5.37
Low52 Date	2026-03-11
Low52ch	3.35%
Ma50ch	-9.55%
Price vs 200-day SMA	-26.09%
RSI	34.91
RSI Monthly	44.99
RSI Weekly	38.44
Sharpe ratio	-0.48x
Sortino ratio	-0.63
Total Return	-5.11%
Tr YTD	-20.6
Tr1m	-11.69%
Tr1w	-5.93%
Tr3m	-17.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -74.6M
Operating margin	-168.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	272,582,593%
Shares Insiders	7.17%
Shares Institutions	18.59%
Shares Out	312,087,324
Shares Qo Q	2.63%
Shares Yo Y	5.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -111.9M
Average Volume	442,551.45x
Bv Per Share	0.81
CAPEX	SEK -68,990
Ch1m	-11.69
Ch1w	-5.93
Ch1y	-35.8
Ch3m	-17.47
Ch3y	671.9
Ch5y	107.1
Ch6m	-24.23
Change	-2.12%
Change From Open	-1.77
Close	5.67
Days Gap	-0.35
Depreciation Amortization	787,891
Dollar Volume	3,502,277.6
Earnings Date	2026-05-11
EBIT	SEK -74.6M
EBITDA	SEK -73.8M
EPS	SEK -0.4
F Score	2
FCF	SEK -111.9M
FCF EV Yield	-6.28x
FCF Per Share	SEK -0.36
Financing CF	103,337,498
Fiscal Year End	December
Founded	2,012
Investing CF	-44,411,174
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	6.92
Ma150ch	-19.8%
Ma20	6.02
Ma20ch	-7.75%
Net CF	-52,938,312
Next Earnings Date	2026-05-11
Open	5.65
Position In Range	25
Ppne	1,038,451
Price Date	2026-05-08
Ptbv Ratio	7.26
Relative Volume	1.43x
Revenue	44,273,192x
Tr6m	-24.23%
Volume	631,041
Z Score	9.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/CRNO.B pay a dividend?

Capital-return profile for this ticker.

Performance

STO/CRNO.B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/CRNO.B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.6%

Share of float held by funds and institutions

Insider ownership

+7.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.1%

Negative means the company is buying back shares.

Technical

STO/CRNO.B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.9

Neutral momentum band

Price vs 200-day MA

-26.1%

50/200-day relationship not available

Beta (5Y)

-0.15

Less volatile than the market

Sharpe ratio

-0.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/CRNO.B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/CRNO.B stock rating?

sto/CRNO.B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/CRNO.B analysis?

The full report lives at /stocks/sto/CRNO.B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/CRNO.B?

The latest report frames sto/CRNO.B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/CRNO.B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.